Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: Evidence-based recommendations

Kidney International, Supplement

Volumn 55, Issue 70, 1999, Pages

  Jindal, Kailash K ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

ANCA; Crescent formation; End stage renal disease; Immune complex; Microvasculitis

Indexed keywords

AZATHIOPRINE; CALCIUM; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DIPYRIDAMOLE; METHYLPREDNISOLONE; PREDNISONE; VITAMIN D; IMMUNOGLOBULIN;

ARTICLE; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; FOLLOW UP; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; ADULT; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PRACTICE GUIDELINE; REVIEW;

ADULT; EVIDENCE-BASED MEDICINE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PLASMAPHERESIS; PRACTICE GUIDELINES;

EID: 0141503579     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. COUSER WG: Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11:449-464, 1988
2. JENNETTE JC, FALK RJ: Diagnosis and management of glomerulonephritis and vasculitis presenting as acute renal failure. Med Clin North Am 74:893-908, 1990
3. WILSON CB, DIXON FJ: Anti-glomerular basement membrane antibody-induced glomerulonephiritis. Kidney Int 3:74-89, 1973
4. JOHNSON JP, MOOR JJ, AUSTIN HB, BALOW JE, ASTONOVYCH TT, WILSON CB: Therapy of anti-glomerular basement membrane antibody disease: Analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore) 64:219-227, 1985
5. SIMPSON IJ, DOAK PB, WILLIAMS LC, BLACKLOCK HA, HILL RS, TEAGUE CA, HERDSON Pb, WILSON CB: Plasma exchange in Goodpasture's syndrome. Am J Nephrol 2:301-311, 1982
6. REES AJ: Goodpasture's syndrome, in Current Therapy in Nephrology and Hypertension, edited by GLASSOCK RJ, St. Louis, Mosby Year Book, 1992, pp 173-178
7. WALKER RG, SCHEINKESTEI, C, BECKER GJ, OWEN JE, DOWLING JP, KINCAID SMITH P: Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome. Q J Med 54:75-89, 1985
8. R. KAPLAN AA: Plasma exchange in renal disease'. Semin Dial 9:61-70, 1996
9. BOLTON WK: Goodpasture's syndrome. Kidney Int 50:1753-1766, 1996
10. LOBO PI, BOLTON WK: Idiopathic rapidly progressive glomerulonephritis, in Current Therapy in Nephrology and Hypertension, edited by GLASSOCK RJ, St. Louis, Mosby Year Book, 1992, pp 235-238
11. NACHMAN PH, HOGAN SL, JENNETTE JC, FALK RJ: Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:33-39, 1996
12. HOGAN SL, NACHMAN PH, WILKMAN AS, JENNETTE JC, FALK RJ: Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:23-32, 1996
13. MADORE F, LAZARUS MJ, BRADY HR: Therapeutic plasma exchange in renal diseases. J Am Soc Nephrol 7:367-385, 1996
14. GLÖCKNER WB, SIEBERTH HG, WICHMANN HE, BACKES F, BAMBAUFR R, BOESKEN WH, BOHLE A, DAUL A, GRABEN N, KELLER F: Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: A controlled, multi-centre study. Clin Nephrol 29:1-8, 1988
15. COLE E, CATTRAN D, MAGIL A, GREENWOOD C, CHURCHILL D, SUTTON D, CLARK W, MORRIN P, POSEN G, BERNSTEIN K: A prospective randomized trial of plasma exchange as additive therapy in idiopathic creseentic glomerulonephritis: The Canadian Apheresis Study Group. Am J Kidney Dis 20:261-269, 1992
16. PUSEY CD, REES AJ, EVANS DJ, PETERS DK, LOCKWOOD CM: Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 40:757-763, 1991
17. RIFLE G, DECHELETTE F: Treatment of rapidly progressive glomerulonephritis by plasma exchange and methylprednisolonc pulses. A prospective randomized trial of cyclophosphamide. Interim analysis. The French Cooperative Group. Prog Clin Biol Res 337:263-267, 1990
18. MAURI JM, GONZALES MT, POVEDA R: Therapeutic plasma exchange in the treatment of rapidly progressive glomerulonephritis. Plasma Ther Transfus Technol 6:587-591, 1985
19. ZENT R, VAN ZYL SMIT R, DUFFIELD M, CASSIDY MJD: Crescentic nephritis at Groote Schuur Hospital, South Africa: Not a benign disease. Clin Nephrol 42:22-29, 1994
20. FALK RJ, JENNETTE JC: ANCA small-vessel vasculilis. J Am Soc Nephrol 8:314-322, 1997
21. YOUNG LS: Pneumocystosis, in Infectious Diseases, edited by HOEPRICH PD, JORDAN MC, RONALD AR, Philadelphia, J.B. Lippincott, 1994, pp 547-553
22. SCIENTIFIC ADVISORY BOARD, OSTEOPOROSIS SOCIETY OF CANADA: Clinical practice guidelines for the diagnosis and management of osteoporosis. Can Med Assoc J 115:1113-1129, 1996
23. SAAG KG, EMKEY R, SCHNITZER TJ, BROWN JP, HAWKINS F, GOEMAERE S, THAMSBORG G, LIBERMAN VA, DELMAS PD, MALICE MP, CZACHURE M, DAIFOTIS AG: Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 339:292-299, 1998
24. ADACHI JD, BENSEN WG, BROWN J, HANLEY D, HODSMAN A, JOSSE R, KENDLER DL, LENTLE B, OLSZYNSKI W, STE-MARIE LG, TENENHOUSE A, CHINES AA: Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 337: 382-387, 1997
25. CAMERON JS: Endocapillary exudative glomerulonephritis, in Diseases of the Kidney (vol 2), edited by SHRIER RW, GOTTSCHALK CW, Boston, Little, Brown, 1996, pp 1948-1953
26. MEDICAL RESEARCH COUNCIL WORKING PARTY: Controlled trial of azathioprine and prednisone in chronic renal disease. BMJ 2:239-241, 1971
27. BOOTH LJ, ABER GM: Immunosuppressive therapy in adults with proliferative glomerulonephritis: Controlled trial. Lancet 2:1010-1013, 1970